Build real-world evidence from longitudinal care journeys.
Nivara can support hospital and academic partners with disease registries, observational studies, screening outcomes, care-pathway analytics and AI validation built around longitudinal patient journeys.
Discuss a Research PartnershipDisease registries
Hypertension, diabetes, CKD, oncology and other longitudinal cohorts under approved governance.
Screening outcomes
Measure screening completion, abnormal-result closure, diagnostic evaluation and navigation.
AI validation
Evaluate accuracy, safety, subgroup performance and clinician oversight before expanding clinical use.
Move from fragmented follow-up to longitudinal evidence.
- Defined research protocol and purpose
- Institutional Ethics Committee review where applicable
- Informed consent or approved waiver as appropriate
- De-identification/pseudonymization and role-based access
- Data minimization and retention controls
- Human oversight for healthcare AI
Potential commercial model
Research services can be contracted as registry setup, study operations, data-quality workflows, approved analytics or sponsored evidence-generation programs. Commercial terms do not override participant rights or ethics requirements.
Start with one clinically meaningful research question.
Define the protocol, governance, cohort and outcome measures before discussing scale.